CD Antigens(CD抗原)
Cell surface antigens of leukocytes are called CD antigens, and important for immune reactions of organisms. As lymphocytes mature, they express different protein receptors on the cell surface, which can aid in determining the type and maturation stage of the cells being examined. These proteins or antigen markers are called Clusters of Differentiation
The term CD means a cluster of differentiation OR a cluster of determinants which indicates the lineage or maturational stage of lymphocytes. During the course of development from precursor cells into functionally mature forms, lymphocytes display a complex pattern of surface antigens, some of which are acquired at certain stages while others are lost.
These surface antigens were identified initially by monoclonal antibodies and the designations of the antibodies were used often as synonyms for the cell surface proteins they detected, giving rise to a plethora of different names. CD antigens are present on some subpopulations and functional types of leukocytes. CD antigens participate in immune reaction as receptors for cell communication (e.g. adherence molecules, antigen recognizing receptors).
CD antigen nomenclature describes different monoclonal antibodies from different sources that recognize identical antigens. Numbers are assigned arbitrarily. A small letter w before the number designation stands for "workshop". It indicates that the CD designation is tentative.
CD antigens are found on practically all known cell types. In some cases CD antigens are expressed only at certain stages of development or under certain conditions, for example after cell activation or in certain disease conditions. In Hematology the morphological criteria is for the description of specific developmental stages of lymphocytes unlike in CD antigens which the use of monoclonal antibodies allows the objective and precise analysis and standardized typing of mature and immature normal and malignant cells of all hematopoietic cell lineages. The use antibodies also helps to delineate the biologic traits that distinguish normal immune and hematopoietic cells from their malignant counterparts, which is utmost important in the understanding of hematological malignancies.
The expression of CD antigens is influenced by cytokines, such as binding of ligands to CD antigens which has shown to modulate the expression of cytokines. CD antigens have been shown to be identical with receptors of cytokines such as CD25 (TAC antigen).
CD antigens appear to carry out cytokine receptor-like functions such as CD27, CD30 and CD40. CD antigens are involved in modulating the biological activities of cytokines such as CD4, CD28 and CD40. CD antigens exist also in soluble forms for example CD14, CD21, CD23, CD27, CD100 and CD137.
The CD Antigen’s designation isn’t related to the biological function, thus CD antigens include receptors, glycans, adhesion molecules, membrane-bound enzymes, etc.
The most commonly know CD antigens are CD4 and CD8 which are markers for T-helper and T-suppressor cells, respectively. CD4 binds to relatively invariant sites on class II major histocompatibility complex molecules outside the peptide-binding groove, which interacts with the T-cell receptor. CD4 is also the central docking receptor for human immunodeficiency virus. CD8 binds to relatively invariant sites on class I major histocompatibility complex molecules outside the peptide-binding groove. CD8 is also expressed on a subset of dendritic cells. Other more important CD antigens include the leukocytes integrins (CD11/CD18) and the hematopoietic stem cell marker CD34.
CD69 is homologous to members of a supergene family of type II integral membrane proteins having C-type lectin domains. Although the precise functions of the CD-69 antigen is not known, evidence suggests that these proteins transmit mitogenic signals across the plasma membrane and are up- regulated in response to lymphocyte activation
In the last decade the wide palette of monoclonal antibodies has been prepared which recognise of CD antigens on human cells. Much less monoclonal antibodies are available specific for typing of domestic animal cells. CD antigens have been characterized as both transmembrane proteins and cell surface proteins anchored to the plasma membrane via covalent attachment to fatty acid-containing glycolipids such as glycosylphosphatidylinositol (GPI).
Products for CD Antigens
- CD1(4)
- CD14(5)
- CD164(2)
- CD2(5)
- CD200(5)
- CD204(2)
- CD207(2)
- CD226(2)
- CD23(2)
- CD244(2)
- CD247(2)
- CD27(3)
- CD274(3)
- CD3(28)
- CD300(4)
- CD33(2)
- CD34(3)
- CD36(2)
- CD4(5)
- CD40(2)
- CD46(2)
- CD47(7)
- CD5(2)
- CD55(2)
- CD58(2)
- CD5L(3)
- CD68(3)
- CD7(2)
- CD73(12)
- CD74(2)
- CD79(3)
- CD80(1)
- CD84(2)
- CD8B(2)
- CD93(2)
- CD99(2)
- Fc Fragment of IgG Receptor(6)
- Other CD Antigens(46)
- sCD40L(5)
- LAG-3(3)
- Mucin(4)
- CD38(2)
- CD19(1)
- Cat.No. 产品名称 Information
-
GP26239
CD276 Mouse
CD276 produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 226 amino acids (29-248a
-
GP26238
CD27 Human, HEK
CD27 Human Recombinant produced in HEK cells is a single, glycosylated, polypeptide chain (20-191 a
-
GP26237
CD21 Human
CD21 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 959 amino acids (21-971aa) and having a molecular mass of 105
-
GP26236
CD9 Human, HEK
CD9 Human Recombinant produced in HEK293 Cells is a single, glycosylated polypeptide chain containing 93 amino acids (112-195a
-
GP26235
CD9 Human, Sf9
CD9 produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 326 amino acids (112-195a
-
GP26234
CD8A Human
CD8A Human Recombinant produced in Baculovirus is a single, glycosylated, polypeptide chain containing 170 amino acids (22-182aa) and having a molecular mass of 18
-
GP26233
CD6 Human
CD6 produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 627 amino acids (18-402a
-
GP26202
ALCAM (CD166) Mouse
ALCAM mouse produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 739 amino acids (28-527a
-
GP26070
sCD40L Human, His Active
sCD40L Human Recombinant produced in E
-
GC68386
CD73-IN-5
CD73-IN-5 是一种有效且选择性的非核苷酸小分子 CD73 抑制剂(IC50 = 19 nM)。
-
GC68346
Uliledlimab
TJ004309
Uliledlimab 是一种有效的抗 CD73 人源单克隆抗体。Uliledlimab 抑制胞外单磷酸腺苷 (AMP) 向腺苷的转化。Uliledlimab 可用于癌症的研究。 -
GC68344
Mupadolimab
CPI-006
Mupadolimab (CPI-006) 是一种 IgG1κ 人源化的 FcγR 结合缺陷抗 CD73 单抗,激活 CD73POS B 细胞。 -
GC65470
Oleclumab
奥来鲁单抗,MEDI9447
Oleclumab (MEDI9447) 是一种人 IgG1Λ 抗 CD73 单克隆抗体,可抑制 CD73 功能。Oleclumab 具有抗肿瘤活性。 -
GC65293
AB-680
AB-680 是一种有效、可逆、选择性的 CD73 (胞外核苷酸酶) 抑制剂,对 hCD73 的 Ki 值为 4.9 pM,对其选择性是对相关胞外核苷酸酶 CD39 的 10000 多倍。具有抗肿瘤活性。
-
GC62695
OP-5244 sodium
OP-5244 sodium 是一种有效和具有口服活性的 CD73 抑制剂,IC50 值为 0.25 nM。OP-5244 sodium 通过阻断腺苷的产生来逆转免疫抑制作用,具有进行癌症研究的潜力。
-
GC62694
OP-5244
OP-5244 是一种有效和具有口服活性的 CD73 抑制剂,IC50 值为 0.25 nM。OP-5244 通过阻断腺苷的产生来逆转免疫抑制作用,具有进行癌症研究的潜力。
-
GC62452
CD73-IN-4
CD73-IN-4 是一种高效、选择性的亚甲基膦酸 CD73 抑制剂,对人 CD73 作用的 IC50 值为 2.6 nM。CD73-IN-4 在癌症免疫学研究中具有潜在的应用价值。
-
GC62331
CD73-IN-3
5-[6-甲基-5-[(1S,2R)-2-丙-2-基环丙基]哒嗪-3-基]-1H-嘧啶-2,4-二酮
LY-3475070 is a potent, selective and orally bioavailable inhibitor of the ectoenzyme CD73 (cluster of differentiation 73, 5'-ecto-nucleotidase, 5'-NT, ecto-5'-nucleotidase). -
GP24134
CD163 Porcine
CD163 Porcine Recombinant
-
GP24133
CD163 Human
CD163 Human Recombinant
-
GP24070
NT5E (CD73) Mouse
5'-Nucleotidase Ecto (CD73) Mouse Recombinant
-
GP24069
NT5E (CD73) Human
5'-Nucleotidase Ecto (CD73) Human Recombinant
-
GP23966
MS4A1 Human
Membrane Spanning 4-Domains A1 Human Recombinant
-
GP23965
MSR1 Human, sf9
Macrophage Scavenger Receptor 1, sf9 Human Recombinant
-
GP23964
MSR1 Human
Macrophage Scavenger Receptor 1 Human Recombinant
-
GP23696
IGLL1 Human
Immunoglobulin Lambda-Like Polypeptide 1 Human Recombinant
-
GP23483
FCGR3B Human
CD16b Human Recombinant
-
GP23482
FCGR3A Human, Sf9
CD16a Human Recombinant, Sf9
-
GP23481
FCGR3A Human
CD16a Human Recombinant
-
GP23480
FCGR2B Human
CD32 Human Recombinant
-
GP23479
FCGR2A Human
CD32a Human Recombinant
-
GP23478
FCGR1A Human
CD64 Human Recombinant
-
GP23236
CRTAM Human
Cytotoxic and Regulatory T Cell Molecule Human Recombinant
-
GP23096
CD300E Human
CD300E Human Recombinant
-
GP23095
CD300A Human
CD300A Human Recombinant
-
GP23094
CD207 Human, sf9
CD207 Human Recombinant, sf9
-
GP23093
CD207 Human
CD207 Human Recombinant
-
GP23092
CD200R1 Mouse
CD200 Receptor 1 Mouse Recombinant
-
GP23091
CD200R1 Human
CD200 Receptor 1 Human Recombinant
-
GP23090
CD200 Human, Sf9
CD200 Human Recombinant, sf9
-
GP23089
CD200 Human
CD200 Human Recombinant
-
GP23088
CD160 Human
CD160 Human Recombinant
-
GP23087
CD100 Human HEK
CD100 Human Recombinant HEK
-
GP23086
CD99 Human, Sf9
CD99 Human Recombinant, Sf9
-
GP23085
CD99 Human
CD99 Human Recombinant
-
GP23084
CD96 Human
CD96 Human Recombinant
-
GP23083
CD93 Mouse
CD93 Mouse Recombinant
-
GP23082
CD93 Human
CD93 Human Recombinant
-
GP23081
CD90 Human
Thy-1 Cell Surface Antigen Human Recombinant
-
GP23080
CD84 Human, Sf9
CD84 Human Recombinant, Sf9